Carbamazepine-associated exfoliative dermatitis.
D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D005260:Female; D006801:Humans; D012640:Seizures / Q000188:drug therapy
D002220:Carbamazepine